Human epidermal growth factor receptor 2 (HER2, which is encoded by the ERBB2 gene), is amplified and/or over-expressed in 10%-25% of human breast cancers, being as it is a member of the epidermal growth factor receptor family. This evidence concerns the gene ERBB2 and breast carcinoma.